Informative Alert COVID-19: Health and Lifesciences Perspective
The European Commission has developed a question -and- answer document to provide guidance to pharmaceutical companies regarding some regulatory measures that can be applied with the aim of coping with the consequences of COVID-19. The guide has been enacted by The European Commission, the [...]